295 related articles for article (PubMed ID: 29151274)
1. Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.
Szczepanik A; Hulbert A; Lee HJ; Benedetti C; Snyder L; Byrns J
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29151274
[TBL] [Abstract][Full Text] [Related]
2. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
[TBL] [Abstract][Full Text] [Related]
3. Statin use is associated with improved function and survival of lung allografts.
Johnson BA; Iacono AT; Zeevi A; McCurry KR; Duncan SR
Am J Respir Crit Care Med; 2003 May; 167(9):1271-8. PubMed ID: 12615629
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
5. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI.
Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
[TBL] [Abstract][Full Text] [Related]
7. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
8. Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients.
Zhang D; Wang X; Du W; Qin W; Chen W; Zuo X; Li P
Pulm Pharmacol Ther; 2023 Oct; 82():102243. PubMed ID: 37454870
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
10. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
11. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
12. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients.
Siddiqui AS; Kumar G; Majumdar T; Graviss EA; Nguyen DT; Goodarzi A; Kaleekal T
Clin Transplant; 2018 Oct; 32(10):e13397. PubMed ID: 30192029
[TBL] [Abstract][Full Text] [Related]
13. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
[TBL] [Abstract][Full Text] [Related]
14. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
[TBL] [Abstract][Full Text] [Related]
16. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
17. Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction.
January SE; Fester KA; Bain KB; Kulkarni HS; Witt CA; Byers DE; Alexander-Brett J; Trulock EP; Hachem RR
Clin Transplant; 2019 Oct; 33(10):e13708. PubMed ID: 31494969
[TBL] [Abstract][Full Text] [Related]
18. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
[TBL] [Abstract][Full Text] [Related]
20. Lung transplant outcomes are influenced by severity of neutropenia and granulocyte colony-stimulating factor treatment.
Tague LK; Scozzi D; Wallendorf M; Gage BF; Krupnick AS; Kreisel D; Byers D; Hachem RR; Gelman AE
Am J Transplant; 2020 Jan; 20(1):250-261. PubMed ID: 31452317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
